Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature

Tumor necrosis factor inhibitors (anti-TNFs) are widely used therapies for the treatment of inflammatory bowel diseases (IBD); however, their administration is not risk-free. Heart failure (HF), although rare, is a potential adverse event related to administration of these medications. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Grillo, Thais Gagno, Silveira, Caroline Ferreira da Silva Mazeto Pupo, Quaglio, Ana Elisa Valencise, Dutra, Renata de Medeiros, Baima, Julio Pinheiro, Bazan, Silmeia Garcia Zanati, Sassaki, Ligia Yukie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237008/
https://www.ncbi.nlm.nih.gov/pubmed/37274378
http://dx.doi.org/10.4330/wjc.v15.i5.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237008/
https://www.ncbi.nlm.nih.gov/pubmed/37274378
http://dx.doi.org/10.4330/wjc.v15.i5.217

Ejemplares similares